Localization of the VEGF and angiopoietin genes in uterine carcinosarcoma

Gynecologic Oncology

Volumn 95, Issue 3, 2004, Pages 474-482

  Emoto, Makoto ^a,b   Charnock Jones, D Stephen ^a   Licence, Diana R ^a   Ishiguro, Masako ^b   Kawai, Michiyasu ^c   Yanaihara, Atsushi ^a   Saito, Toshiaki ^d   Hachisuga, Toru ^b   Iwasaki, Hiroshi ^b   Kawarabayashi, Tatsuhiko ^b   Smith, Stephen K ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b FUKUOKA UNIVERSITY   (Japan)

^c TOYOHASHI MUNICIPAL HOSPITAL   (Japan)

^d National Kyushu Cancer Hospital   (Japan)

Author keywords

Angiogenesis; Angiopoietin; Carcinosarcoma; Endometrial carcinoma; Microvessel density; Vascular endothelial growth factor; Vascular invasion

Indexed keywords

ANGIOPOIETIN 2; MESSENGER RNA; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CARCINOMA CELL; CARCINOSARCOMA; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; GENE EXPRESSION; GENE LOCATION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; SARCOMA CELL; UTERUS CARCINOMA;

AGED; AGED, 80 AND OVER; ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANGIOPOIETINS; CARCINOSARCOMA; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER; UTERINE NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR B; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 9944240425     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.08.042     Document Type: Article

References (44)

1. H.J. Norris, and H.B. Taylor Mesenchymal tumors of the uterus: III. A clinical and pathologic study of 31 carcinosarcomas Cancer 19 1996 1459 1465
2. T.V. Dinh, R.E. Slavin, B.S. Bhagavan, E.V. Hannigan, E.M. Tiamson, and R.B. Yandell Mixed müllerian tumors of the uterus: a clinicopathologic study Obstet. Gynecol. 74 1989 388 392
3. A.G. Östör, and T.P. Rollason Mixed tumours of the uterus H. Fox M. Wells Haines and Taylor fourth ed. Obstet. Gynaecol. Pathol. vol. 1 1995 Churchill Livingstone New York 606 610
4. S.G. Silverberg, F.J. Major, J.A. Blessing, B. Fetter, F.B. Askin, and S.-Y. Liao Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus: a gynecologic oncology group pathologic study of 203 cases Int. J. Gynecol. Pathol. 9 1990 1 19
5. M. Emoto, H. Iwasaki, M. Ishiguro, M. Kikuchi, S. Horiuchi, and T. Saito Angiogenesis in carcinosarcomas of the uterus: differences in the microvessel density and expression of vascular endothelial growth factor between the epithelial and mesenchymal elements Hum. Pathol. 30 1999 1232 1241
6. S.D. Yamada, R.A. Burger, W.R. Brewster, D. Anton, M.F. Kohler, and B.J. Monk Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus Cancer 15 2000 2782 2786
7. E. George, T.J. Lillemoe, L.B. Twiggs, and T. Perrone Malignant mixed mullerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: a comparative analysis of survival Int. J. Gynecol. Pathol. 14 1995 39 44
8. T.A. Longracre, R.L. Kempson, and M.R. Hendrickson Endometrial hyperplasia, metaplasia, and carcinoma H. Fox M. Wells Haines and Taylor fourth ed. Obstet. Gynaecol. Pathol. vol. 1 1995 Churchill Livingstone New York 421 510
9. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat. Med. 1 1995 27 31
10. E. Tischer, R. Mitchell, T. Hartman, M. Silva, D. Gospodarowicz, and J.C. Fiddes The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing J. Biol. Chem. 266 1991 11947 11954
11. C.A. Boocock, D.S. Charnock-Jones, A.M. Sharkey, J. McLaren, P.J. Barker, and K.A. Wright Expression of vascular growth factor and its receptors flt and KDR in ovarian carcinoma J. Natl. Cancer Inst. 87 1995 506 516
12. G.M. Abu-Jawdeh, J.D. Faix, J. Niloff, K. Tognazzi, E. Manseau, and H.F. Dvorak Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms Lab. Invest. 74 1996 1105 1115
13. A.J. Guidi, G.M. Abu-Jawdeh, K. Tognazzi, H.F. Dvorak, and L.F. Brown Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma Cancer 78 1996 454 460
14. H.M. Sowter, A.N. Corps, A.L. Evans, D.E. Clark, D.S. Charnock-Jones, and S.K. Smith Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumor Lab. Invest. 77 1997 607 614
15. K.G. Peters Vascular endothelial growth factor and the angiopoietins: working together to build a better blood vessel Circ. Res. 83 1998 342 343
16. P.C. Maisonpierre, C. Suri, P.F. Jones, S. Barunkova, S.J. Wiegand, and C. Radziejewski Angiopoietin-2, a natural antagonist for Tie 2 that disrupts in vivo angiogenesis Science (Wash. DC) 277 1997 55 60
17. A. Startmann, W. Risau, and K.H. Plate Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis Am. J. Pathol. 153 1998 1459 1466
18. J. Holash, P.C. Maisonpierre, D. Compton, P. Boland, C.R. Alexander, and D. Zagzag Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF Science (Wash. DC) 284 1999 1994 1999
19. T. Etoh, H. Inoue, S. Tanaka, G.F. Barnard, S. Kitano, and M. Mori Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases Cancer Res. 61 2001 2145 2153
20. C. Sfiligoi, A. Luca, I. Cascone, V. Sorbello, L. Fuso, and R. Ponzone Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival Int. J. Cancer 103 2002 466 474
21. N. Mitsuhashi, H. Shimizu, M. Ohtsuka, Y. Wakabayashi, H. Ito, and F. Kimura Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma Hepatology 37 2003 1105 1113
22. Y. Yoshida, T. Kurokawa, N. Fukuno, Y. Nishikawa, N. Kamitani, and F. Kotsuji Markers of apoptosis and angiogenesis indicate that carcinomatous components play an important role in the malignant behavior of uterine carcinosarcoma Hum. Pathol. 31 2000 1448 1454
23. FIGO Annual report on the results of treatment of gynecological cancer Int. J. Gynecol. Obstet. 28 1989 189 193
24. D.E. Clark, S.K. Smith, A.M. Sharkey, H.M. Sowter, and D.S. Charnock-Jones Hepatocyte growth factor/scatter factor and its receptor c-met: localisation and expression in the human placenta throughout pregnancy J. Endocrinol. 151 1996 459 467
25. J.M. Elias, M.M. Margiotta, and D. Gaborc Sensitivity and detection efficiency of the peroxidase antiperoxidase (PAP), avidin-biotin peroxidase complex (ABC), and peroxidase-labeled avidin-biotin (LAB) methods Am. J. Clin. Pathol. 92 1989 62 67
26. J.J. Sreenan, and W.R. Hart Carcinosarcomas of the female genital tract: A pathologic study of 29 metastatic tumors: Further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis Am. J. Surg. Pathol. 19 1995 666 674
27. T. Kato, S. Teshima, S. Watanabe, T. Yamada, K. Tanemura, and R. Tsunematsu The increasing trend in Japan of mullerian mixed tumor of endometrium Jpn. J. Clin. Oncol. 18 1998 303 308
28. M.E. King, and Kramer Malignant mixed müllerian tumors of the uterus: a study of 21 cases Cancer 45 1980 188 190
29. Larsson B. Uterine sarcoma: an epidemiological and clinicopathological study. Dissertation. Stockholm: Karolinska Institute; 1989.
30. R.R. Nordal, and S.O. Thoresen Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality Eur. J. Cancer 33 1997 907 911
31. P. Bitterman, B.K. Chun, and R.J. Kurman The significance of epithelial differentiation in mixed mesodermal tumors of the uterus Am. J. Surg. Pathol. 14 1990 317 328
32. J.J. Sreenan, and W.R. Hart Carcinosarcomas of the female genital tract: a pathologic study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis Am. J. Surg. Pathol. 19 1995 666 674
33. A.P. Levy, N.S. Levy, and M.A. Goldberg Post-transcriptional regulation of vascular endothelial growth factor by hypoxia J. Biol. Chem. 271 1996 2746 2753
34. N. Weidner, J.P. Semple, W.R. Welch, and J. Folkman Tumor angiogenesis and metastasis-Correlation in invasive breast carcinoma N. Engl. J. Med. 324 1991 1 8
35. V. Joukov, K. Pajusola, A. Kaipainen, D. Chilov, I. Lahtinen, and E. Kukk A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinase EMBO J. 15 1996 290 298
36. J. Lee, A. Gray, J. Yuan, S. Luoh, H. Avraham, and W. Wood Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4 Proc. Natl. Acad. Sci. U. S. A. 93 1996 1988 1992
37. B. Olofsson, K. Pajusola, A. Kaipainen, G. von Euler, V. Joukov, and O. Saksela Vascular endothelial growth factor B, a novel growth factor for endothelial cells Proc. Natl. Acad. Sci. U. S. A. 93 1996 2576 2581
38. Y. Yamada, J. Nezu, M. Shimane, and Y. Hirata Molecular cloning of a novel vascular endothelial growth factor, VEGF-D Genomics 42 1997 483 488
39. P. Salven, A. Lymboussaki, P. Heikkila, H. Jasskela-Saari, B. Enholm, and K. Aase Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors Am. J. Pathol. 153 1998 11 16
40. P. O-charoenrat, P. Rhys-Evans, and S.A. Eccles Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis Cancer 1 2001 556 568
41. T. Andre, L. Kotelevets, J.C. Vaillant, A.M. Coudray, L. Weber, and S. Prevot Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa Int. J. Cancer 86 2000 174 181
42. J.C. Gollmer, A. Ladoux, J. Gioanni, P. Paquis, A. Dubreuil, and M. Chatel Expression of vascular endothelial growth factor-b in human astrocytoma Neuro-oncology 2 2000 80 86
43. S. Gunningham, M.J. Currie, C. Han, B.A. Robinson, P.A. Scott, and A.L. Harris VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis J. Pathol. 193 2001 325 332
44. G. Silins, S. Grimmond, M. Egerton, and N. Hayward Analysis of the promoter region of the human VEGF-related factor gene Biochem. Biophys. Res. Commun. 230 1997 413 418